NCT06684535View on ClinicalTrials.gov

Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

July 7, 2025

Study Completion Date

July 7, 2025

Conditions
DexmedetomidineAdjuvantExternal Oblique Intercostal Plane BlockThoracotomyPain
Interventions
DRUG

Dexmedetomidine

Patients will receive 29 ml bupivacaine 0.25% + 1 ml dexmedetomidine 0.5 μg/kg.

DRUG

Saline

Patients will receive 29 ml bupivacaine 0.25% + 1 ml saline.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06684535 - Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain | Biotech Hunter | Biotech Hunter